Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The stock traded as high as $21.32 and last traded at $21.29, with a volume of 225039 shares trading hands. The stock had previously closed at $21.24. Analyst Ratings Changes Several analysts have commented on […]
Royal Bank of Canada Reiterates Sector Perform Rating for Fusion Pharmaceuticals (NASDAQ:FUSN) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Jefferies Financial Group reaffirmed their hold rating on shares of Fusion Pharmaceuticals (NASDAQ:FUSN – Free Report) in a research report report published on Tuesday, Marketbeat reports. They currently have a $21.00 price target on the stock, up from their prior price target of $10.00. FUSN has been the topic of several other reports. William Blair […]
Shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) have been given a consensus recommendation of “Buy” by the eight analysts that are currently covering the stock, Marketbeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […]
Fusion Pharmaceuticals (NASDAQ:FUSN – Get Free Report)‘s stock had its “outperform” rating reissued by stock analysts at William Blair in a research report issued on Friday, RTT News reports. Other analysts have also recently issued research reports about the company. Royal Bank of Canada started coverage on Fusion Pharmaceuticals in a research report on Wednesday, […]